Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (388)
- Scheduling (national classification system) (171)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
770 result(s) found, displaying 26 to 50
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 March 2025
-
TGA laboratory testing reportsThis study by the TGA assesses the particle filtration efficiency of respirators listed in the ARTG or submitted for compliance testing during the COVID-19 pandemic.
-
Meeting statementsThe 86th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 14 August 2025.
-
TGA laboratory testing reportsFace masks that are intended by their manufacturer to prevent the transmission of diseases between people or are intended to be used in a healthcare environment, are medical devices
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
TGA laboratory testing reportsTGA laboratories Branch tested various seasonal influenza vaccine batches.
-
TGA laboratory testing reportsBetween November 2024 and April 2025, TGA, Laboratories Branch tested various Heparin products
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 53
-
TGA laboratory testing reportsThis report summarises the extensive batch release testing activities undertaken by the TGA Laboratories for COVID-19 mRNA vaccines.
-
TGA laboratory testing reportsThis survey focused on single-ingredient vitamin D3 products with high sales volumes in Australia between January and December 2023. The TGA tested 13 of the top-selling products, which were supplied by nine different sponsors.
-
Corporate reportsThe Australian Sunscreen Exposure Model performs sunscreen exposure calculations that reflect the unique conditions and practices in Australia.
-
Meeting statementsCommunique from the 9th meeting of the WHPWG 27 March 2025
-
Corporate reportsRead our business plan 2025-26 to find out about our strategic priorities and activities.
-
Corporate reportsDocuments released under the FOI Act in the 2024/25 financial year
-
Meeting statementsThe 85th meeting of the Advisory Committee on Medical Devices (ACMD) was held on 12 June 2025.
-
Corporate reportsBased on the data considered in this safety review, we recommend regulatory controls for homosalate and oxybenzone to restrict their permitted concentrations and use in therapeutic sunscreens.
-
Corporate reportsThis updated safety review uses the Australian Sunscreen Exposure Model to assess the risk of benzophenone as a degradant in sunscreens.
-
Corporate reportsThis Cost Recovery Implementation Statement (CRIS) 2025-2026 provides information on how we implement, and cost recover our regulatory activities.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 27 July 2025
-
Scheduling submissionsFind out about the public submissions on scheduling matters referred to the ACMS #46 meeting held in November 2024
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Meeting statementsCommunique from the 8th meeting of the Women's Health Products Working Group (WHPWG), 30 October 2024.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement 52
-
Scheduling decisions (final)This web publication constitutes a notice for the purposes of regulation 42ZCZS and regulation 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations).